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Precipitating anti-PM-Sel antibo<lies are present 
in sera from patients with polymyositis. sclero-
derma. and polymyositis/scleroderma overlap syn-
dromes. By indirect immunofluorescence micros-
copy. anti-PM-Scl antibodies stained the nucleolus 
in cells of different tissues and species. suggesting 
that the antigen is highly conserved. By electron 
microscopy, anti-PM-Scl antibodies reacted primar-
ily with the granular component of the nuc1eolus. 
Drugs that inhibit rRNA synthesis had a marked 
effect on the expression of PM-Scl antigen. In acti-
nomycin D-treated cells, immunofluorescence 
staining by anti-PM-Scl was signüicantly reduced 
with residual staining restricted to the granular 
regions of nuc1eoli. Treatment with 5,6-dichloro-ß-
o-ribofuranosylbenzimidazole (DRB) also selec-
tively reduced nuc1eolar staining. On a molecular 
level, anti-PM-Sel antibodies precipitated 11 poly-
peptides with molecular weights (Mr) ranging from 
110,000 to 20,000. The Mr 80,000 and 20.000 poly-
peptides were phosphorylated. Evidence suggests 
that the PM-SeI antigen complex may be related to 
a prerlbosomal particle. 
AutoanUbodles agalnst nucleic acids and a variety of 
cellular proteins and RNA protein complexes are pro-
duced by paUents with systemic autoimmune disease (1). 
These serum antibodies not only are of diagnostic signif-
icance, e.g., anti-native DNA and anti-Sm anUbodies for 
systemic lupus erythematosus (2, 3), but also have proved 
to be valuable immunologic tools in molecular and cellu-
lar biology. For example, anUbodles against U1 ribonu-
cleoproteln were shown to effecUvely inhlblt splicing of 
heterogeneous nuclear RNA, thus ImplicaUng this nu-
clear ribonuc1eoprotein particle in the processing of 
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mRNA (4). Most recently, antibodtes against the Sm ri-
bonueIeoprotein partieIe that is complexed with uridine-
rieh smaU nueIear RNA, named UI. U2, U4, U5, and U6 
(5), have facilltated cloning of cDNA that contains se-
quences complementary to mRNA for the E protein (Mr 
11,000) of the Sm partieIe (6). 
In arecent paper, a new preclpitatinganUgen-antibody 
system termed PM-SeI was described In patients with 
polymyosiUs, scleroderma. and polymyoslUsjsclero-
derma overlap syndromes (7), These antlbodtes have 
identlcal specificities as antl-PM-1 antlbodies, which had 
been prevtously reported In patients with polymyositis 
(8). The immunofluorescence patterns obtained with 
anti-PM-Scl sera were initially described as being both 
nueIeolar and nucleoplasmic in nature. Recently, Targoff 
and Reichlin (9) provlded evldence for a nucleolar locali-
zation of the PM-Scl antigen. Although some Mr data on 
the PM-SeI antigen were recently reported by Bernstein 
et aL (10), the macromolecular nature and origin of the 
PM-SeI antigen remain unknown. To understand the 
significance of autoanUgens in the context of diseases 
with which they are assoctated, it may be important to 
elueidate their structure and funetion. In this study, we 
have shown that the PM-Scl antigen is a complex partlcle 
composed of at least 11 polypeptides. We further provlde 
evidence that the PM-Scl antigen complex may be of 
preribosomalorigin. 
MATERIALS AND METHODS 
Patient sera. Antl-PM-Sel sera were obtalned from patlents with 
polymyositIs, sclerodenna, or polymyoslUs/sclerodenna ovedap syn-
dromes and were selected from the serum bank of thls laboratory. 
Thelr Immunologie speclflclty was assessed by double ImmunodIf-
fusion agalnst a reference anU-PM-SeI serum (S.8 .) as descrtbed (7) . 
Thls serum had also been the standard reference serum In the latter 
study. 
lndtrect Immunofluorescence. Sera were dlluted startlng at 1/40 
In phosphate-buffered saline (PBS). pH 7 .4 . and used for Indlrect 
Immunofluorescence. Substrates Included commerclally avallable 
Hep-2 cells (Blon, Park Rldge, IL) and KB cells (Electronucleonlcs. 
Bethesda, MD). Other substrates were Vero and HeLa cells grown on 
mlcroscoplc sildes and flxed In acetone/methanol at 3 :1 for 3 mln. 
unstlmulated and concanavaltn A (Con A)-stlmulated human pertph-
eral blood Iymphocytes, T cell lymphoma Molt 4 cells. rat RV cells. 
rat kangaroo PTK2 cells. flsh FHM cells. turtle TH-l cells, duck 
(Pe kin duck) embryonlc cells. and rat IIver cryostat sectlons. The 
duck embryonie. FHM. and TH-l cells were obtained from the Amer-
Ican Type Culture Collectlon. Rockvllle, MD; the other cells. from 
stocks In thls and Or. Scheer's 1aboratory. A fluoresceln goat antl-
human IgG conJugate (Tago, Burllngame, CA) was the detectlng 
reagent. Intenslty of Immunofluorescence was graded from weak 
(+), to moderate (++), to strong (+++). Double Immunofluorescence 
stalnlng wlth the use of a mouse monoclonal antlnucleolar antlbody 
of IgG2a Isotype and human anti· PM-SeI serum was perfonned as 
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descrlbcd (I I ). ResullS were read on a Lellz Ortholux II fIuorescence 
rnlC'roscope . 
f;/ecfroll mtcroscopic Immunocytochemlsfry. A representatlve 
antl -PM-Scl serum (5125) was dlluled 1/ 100 In PBS and incubaled 
for 2 hr w!th frozen sectlons (5-l'm lhickness) of regcneraling rat 
livcr t hat had been flxed In acetone al -20°C for 10min. After 
scvcral washcs In PBS. goal anti-human IgC coupled 10 colloldal gold 
partlclcs of 5-nm diameter (Janssen Life Sclences. Beerse. Belglum) 
was added at a dilution of 1/4. After overnlghl incubation at 4°C. 
the speeirnens were f1xed and processed for electron mlcroscopy as 
deserlbed In detail elsewhere (12) . 
Drug studtes. TIssue ulture Vero cells were Incubated wllh me-
dium contalnlng 0 . 1 I'g/ml actlnomycln D for 4 hr and wlth 50 I'g/ 
mI5.6-dlchloro-I-ß-o- ribofuranosylbenzlmldazole (DRB).· a halogen-
ated adenosine analogue. for 6 hr. Both drugs were purchased from 
8ehring Dlagnoslics. La Jolla. CA. After drug treatment. cells were 
f1xed and processed for indirecl immunofluorescence or double Im-
rnunofIuorescence stainlng as describcd. 
Nuc/ease digestion experiments. For nuclease digestion experi-
ments. Vcro cells were grown on mlcroscopic slides and f1xed as 
dcsrribcel above. The cells were then dlgested wlt.h 0.25 mg/mi 
DNase I (MIllipore. Freehold. NJ) in PBS containing 5 mM MgCI2 and 
2 mM phenylmethylsulfonylfluorlde (PMSF) or wlth 0.25 mg/mi 
RNa e A (Milli pore) In PBS for 30 mln at 37"C. After digestion. cells 
were washed in PBS and processed for Inellrecllmmunofluorescence. 
ßurfers wlltlOut enzymes serveel as negative controls. 
ImmuTlopreclpltation. HeLa cells were metabollcally labeled wlth 
I35Sjmethlonlne and 132Pjorthophosphate (New England Nuclear. Bos-
ton. MA). Iyseelln buffer A (10 mM Trls-HCI. pH 7.4. ISO mM NaCI. 
10 mM MgCh. 0 .5% Nonldet P-40. and 2 mM PMSF). and further 
proeessed as described (13) wlth mocllflcallons. All experIments were 
performed In Eppenelorf mlcrocenlrlfuge tubes at O°C to 4°C. In brief. 
sampies of 101'1 of patient serum were mixed for I hr wlth 1001'1 of 
protein A-Sepharose CL-4B [Pharmacla. Uppsala. Sweden) sus-
peneled at 10% (v/v) In buffer B (10 mM Trls-HCI. pH 7.4.150 mM 
NaCI. 10 mM EDTA. 0 . 1 % dcoxycholate. 0 . 1 % sOOlum dOOecyl sulfate 
ISOSI 0.5°;' Nonldet 1'-40 23 U/ml Kalilkrein Inactlvator IBehrlng 
Diagnosticsll supplemented wlth 2 mg/mi bovlne serum albumin. 
After washing wlth buffer B. 100 1'11. of 3~S_ 01' 32P-Iabeled HeLa cell 
cxtract was added anel Incubateel for I hr with constanl mixing. The 
beaels wert' then washed five ttmes In buffer B. boileel In Laemmll 
sampie buffer (14) and processed by SDS-polyacrylamide gel electro-
phoresis (SDS-PACE). followed by aUloradlography at -70°C. Half of 
the 32p pellet was processed by SDS-PAGE and the olher half was 
phenol eXlracted: any RNA was preclpilated in ethanol. RNA analy-
sis was performed in 7 M urea. 8% polyacrylamide gels followed by 
autoradlography as described (5). 
RESULTS 
ImmunoJluorescence stalning with anti-PM-Scl antl -
bodies with the use oJ dljJerent cell substrates_ Various 
celllines and tlssues were used as substrates for stalning 
wllh antl-PM-Sc1 sera from different patients. The stain-
Ing patterns observed wlth a representative anti-PM-Scl 
serum (S (25) are shown In Figure 1. [n human HeLa ce[[s 
(Fig. [a and b). monkey Vero cells (Fig. Je and d). and 
mitogen-stlmu[ated human periphera[ b[ood [ymphocytes 
(Fig. 1 e and J). anti-PM-Scl antibodies strongly (+++) 
stained the Interior of nuc)eo[i. Weak nuc)eoplasmic 
staining (+) was also observed with most of these sub-
strates. The homogeneous nuc[eolar sta[ning pattern was 
uniformly observed in all substrates tested. including 
cells such as human Molt 4 cells. rat RV cells. marsuplal 
PtK2 cell . and rat liver sections. In unstlmulated perlph-
eral blood lymphocytes. PM-Scl staining was consider-
ably weaker (+) when compared with Con A-stimulated 
lymphocytes. which gave a (+++) stainlng (Fig. 1e andJ). 
1n addition. Pm-Scl staining was also present In fish FHM 
rells. turtle TH-l ceJls. and a duck embryo cell line. 
su~e ting that the epitopes recognized by anti-PM-Sc1 
anUbodies are widely conserved In evolution. All anti-
PM-Scl sera tesled so far produced comparab1e nuc[eo1ar 
• Abbrcvlallons used In lhls paper: PM5F. phenylmethylsulfonylfluor-
Ide: DRB. 5.6 dlchloro-ß-o-rlbofuranosylbenzlmldazole. 
Figure I. Immunofluorescence stalning of HeI..Il cells (0). Vel'o cells 
(cl . and eon A-sllmulaled human perlpheral blood lymphocytes (e) \Vllh 
3utolmrnune hllman antl-PM-Scl anllbodles [5125). All nucleoll dernon -
strale brlght homogeneous nucleolar stalnlng 10 all cells tesled . Wcak 
nllcleoplasrnlc slalnlng Is also present. especlally In Vero cells . Note 
prenucleolar body slalnlng (arrows) of a telophase HeLa cell In a. Slmllar 
results were obtalned wlth all the sera tcsted . For comparlson. lhe cells 
are shown In phase contrasl (b. d . and!). Bars 10 "m. X 1450. 
stainlng patterns in different cell substrates. 
Anti-PM-Scl staining during cell cycle. Figure 2a and 
b shows indirect immunofluorescence wlth rat kangaroo 
PtK2 cells used as substrate when reacted with a repre-
sentative antl-PM-Scl serum (S 125) from a patient with 
scleroderma. In interphase cells. immunofluorescence 
staining was predominantly wlthln the nucleolus with 
weak (+) staining of the nucleoplasm. In metaphase cells. 
diffuse statning was observed in the area of the con-
densed chromosomes. In anaphase cells. anti-PM-Scl 
slaining was diffusely dlstrtbuted around the chromo-
somes and in the penchromosomal cell plasm.ln telo-
phase. anti-PM-Scl antih:>dies stalned the prenucleolar 
bodies of the reconstituling nucleoll. as shown for HeLa 
cells In Figure 1a (arrows). 
Subnucleolar localization oJ PM-Scl by electron mi-
croscoptc immunocytochemistry. For subnuc1eolar 10-
callzation of the reactive antigen. electron microscopic 
immunocytochemtstry was performed with the tmmu-
nogold label technlque. Ftgure 3a. b. and c shows secUons 
through nucleol! of regenerattng rat liver. IgG from a 
representatfve antl-PM-Sc1 serum (S 125) was localtzed 
primarlly in the granular component of nucleol1. Gold-
antlbody complexes were selecttvely enrlched over lhe 
granular component wlth accentuation over the perlph-
ery of the nucleoli. Immunogold was virtually absent In 
the dense f1brillar component or ftbrillar centers. It 
should be noted that gold-antibody complexes were also 
observed In distlnct clusters dtspersed throughout the 
nucleoplasm as potnted out by arrows (Flg. 3a and cl. 
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Flgure 2. Immunolocaltzatlon 01' anU-PM-5cl antlbodles (5125) In rat 
kangaroo PtK2 cells durlng different phases 01' the cell cycle. as vlsuallzed 
by Immunofluorescence mlcroscopy (a) and phase contrasl (b). In Inter-
phase cells. br1ght nucleolar slalnlng and weak Ilueleoplasmlc slalnlng 
by anll-PM-Scl Is present. Note lhat nucleolar stalning rclocatcs as the 
chromosomes condense durlng metaphase (arrow 1) giving ri se Lo diffuse 
sial nlng In the area of the condenscd chromosomes. in laIe anaphase cell 
(a r row 2). PM -Sei stalning Is diffusely dislr1buted on the surface of the 
chromosomes and In the per1chromosomal cell plasm. Individual chro-
mosomes can be disllngulshed in phase-contrast optics (b) as elongated 
IIghter structures surrounded by dark borders . Bar 20 ~m . x I 040. 
These electron microscopic findlngs glve support to the 
observation that in indirect immunofluorescence there is 
weak nucleoplasmic [n addition to nucleolar staining. In 
[he control experiment. antibodies against RNA polym-
erase I (12) were used that only stained the fibrillar 
centers but not the granular component of nucleolL 
E;[fect oJ actinomycin D and DRB on the distributi.on 
oJ anti -PM-Sc! stainlng. To rurther study the nature of 
the PM-Sei antigen. Vero cells were exposed to the nu-
cleolus-segregatlng drugs actinomycin D and DRB. After 
drug treatment and fixation. cells were incubated with 
severaJ anti-PM-Scl sera and stained with a f1uorescein 
a nti -human IgG conJugate. AcUnomycin D-inactivated 
nucleoli are compact and show a typical segregation of 
the fibrillar component from the granular component. 
usually resulting in the formation of distinct nucleolar 
hemispheres (15 - 17). F[gure 4 shows the results ob-
tained with prototype serum S125. Actlnomycin D at 0.1 
IlgJml considerably reduced nucleolar staining by antl-
PM-Scl antibodles. Residual staining was predominantly 
Flgure 3. Immunolocalizatlon of antl-PM-Scl anllbodtcs (5 125)ln sub-
nuclcolar compartments tn the hepatocytes or regenerattng rat Itver, as 
shown by the electron mlcroscoptc tmmul1ogold label technlque. For 
orlentatton. frame a of thls composite shows seetIons of two nucleoll and 
surroundtng hctcrochromaltn at low magniftcatlon . F'rames band c dem-
onstrate at high magntfteallon two sectlons of nucleoll. The 5-mm gold 
partlcles (small black dors) Indlcatlng gold-anttbody-antlgen complexes 
are selectlvely enriched over the granular component IGC) and are dls-
trlbutcd at hlgher denslty In the perlphcry 01' these nucleoll. The dense 
fibrlliar componenl (DFC) and the ftbr1JJar centers (F'C) are free of gold 
partlcles. Note that gold-antibody-anUgen cornplexes are also present In 
clusters throughout the heterochromaUn structurcs as Indlcated by ur-
rows In a and c . Bars I /Lm, x20.000 (a). 0.2 jJm . x 70 .000 (b) . 0.2 ~1l1 . 
x I 25.000 (c). 
localized in the granular component (Flg. 4b). whlch ap-
peared dark in phase optlcs (Fig. 4c) . When DRB was 
added to Vero cells growing in culture. the normally 
compact nucleoll unraveled Into extended beaded 
strands. again segregatlng the nucleolus Into granular 
and flbrfllar regions as has been descrtbed In prevtous 
studies (18- 20). Treatment of Vero cells wtlh DRB at 50 
IlgJml for 4 to 6 hr substantially removed PM-Sc I statning 
of segregated nucleolar structures (Fig. 4e andJ). How-
ever. diffuse nucleoplasmtc slainlng of low intenslty (+). 
which was not reproduced weil in the micrograph. was 
still present. In contrast. a mouse monoclonal IgG2a a n-
tibody agalnst a M, 34.000 nucleolar protein associated 
with the U3 rlbonucleoprotein particle (Reimer ct aL. 
manuscript In preparatlon) still strongly reacted wlth the 
flbrllJar component of act!nomycin D- and DRB-segre-
ga ted nucleoli (Flg. 4a and d) . These observations show 
lhat actinomyctn D and DRB significantly affect expres-
sion of PM-Scl antigen. leavlng another nucleolar protein 
essentiaJly unaffected. 
Nuclease digestion studtes. To evaluate the effect of 
nuclease digestion on PM-Scl antigen. HeLa cells were 
Incubated with DNase and RNase be fore tncubatlon with 
antl-PM-Scl serum. Nelther of these nucleases substan-
tially altered intenslty of nucleolar lmmunofluorescence 
stalntng when compared wtth controls In which buffers 
wlthout enzyme were used. In other control experiments. 
nuclear staining by a monoclonal anti -native DNA anti-
body (11) was abolished by DNase pretreatment of cells. 
and nucleolar and cytoplasmic stainlng produced by hu-
man and monoc\onal antl-RNA antibodles was abolished 
by RNase pretreatment. These ftndtngs suggested that 
the antigenictty of PM-SeIls not dependent on DNA or 
RNA. 
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VIgil re 4 Double ,mmunofluorescence stalnlng. 11 mouse monoclonal 
IgG2a anubody 3/i!alnst flbrilluin. a basic nllcleolar protein. and human 
anU -PM -Scl anllbodles (S 125) was reuelcd simllltMleously wtth acUno-
m ycln D- 10 and b) and DHß- (d and e) lreated Vero cells . Thc IgG2a mouse 
monO<'lonal antlbody (0 and d) was deteeted wtth a SPN'lfic f!uoresceln 
conJlIg"tc; thc human antlbodle . wllh an antl-rgG rhodamlne conJugate 
(b and e). Stalning Inlcnslty of f1brlllar componen ts of nucleolf by mono-
c l(>l'la I antlbocly to flbrillarin was nOI slgnlflcan tly affccted byactlnomycln 
o (al or DRB (cl) . In eon lrast. anll·PM-Sel anllbodles thai reaeled wlth t11 C 
granular eomponent (arrow) showed conslderably reduced stalnlng Inten· 
slty after actlnomycln D trealment (b) when eompa red wlth unlrealed 
nuclcolf (for eomparlson see rlg. l e) . DRB treatment almost completcly 
abollshecl anll -PM-Scl lalnlng of dlspersed nucleolar structures (e) . ror 
rC"fcrf'nce . ce lls are also hown In phase·contrast opucs Ic andJ). Bar 10 
pm. x 1450. 
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Ftgure 5. Autoradiogram of Immunopreclpltated f"Slmeth lonlne-la-
beled HeLa eell proteins elec trophorell ca lly rcsolvecl In a 15% SOS-poly-
acryla mide gel. Lane 1. normal human serum; lane 2 to 7. antl-PM-Scl 
sera as Identlfted prevlously In Immunodiffusion; lane 8. molecular 
welght markers. A group of dlstlncl polypeptides were unlformly preclp-
Itated by a ll anll-PM-Scl sera but not by normal cont rol serum. 
MolecuLar character ization OJ the PM-Scl antigen. To 
identlfy the molecular composition of the PM-Sei antigen. 
we performed protein A-faeilltated immunopreeipitatlon 
of rad iolabeled a ntigen followed by gel analysis. Immu-
nopreeipitation with slx a nti -PM-SeI sera. using [35Slme-
lhionine-Iabeled HeLa cell extract. followed by SDS-
PAGE analysis are shown in Figure 5. lanes 2 to 7. All 
sera wlth PM-ScI specificity by double Immunodiffusion 
uniformly precipltated at least II polypeptides (PI-PlI) 
with Mr 110 .000. 90.000. 80.000. 39.000. 37.000. 
33.000. 30.000. 27.000. 26.000. 22.000. and 20.000. 
Figure 6. lane 2. shows In detail the polypeptides preclp-
itated by representative anti-PM-ScI serum S125. On 
eloser examination of Figure 5 it ean be nottced that there 
are additional polypeptides present in lanes 3. 4, and 5. 
but the common polypeptides preclpilated by all sera 
examined comprlsed the PI-PlI complex as shown in 
Figure 6. 
HeLa cells were labeled with e2 Plorthophosphate. and 
the cell Iysate was used In immunopreclpitatlon to deter-
mine wh ether the PM-Scl antigen might be phosphory-
lated or associated with tightly bound RNA. The Mr 
80.000 (P3) and 20.000 (P I I) polypeptides that were 
precipltated by anti-PM-Sel antibodies were phosphopro-
teins (Fig. 7. lane 4) . RNA was not pa rt of the PM-Sei 
antigen as shown by absence of RNA in urea-polyacryl -
amide gels. We also incubated deprotelnized RNA from 
HeLa cells wlth anti-PM-Scl antibodles but fall ed to dem -
onstrate any binding with RNA. suggesting that RNA 
itself is not a target (data not s hown) . The latter data are 
In agreement with the in situ nuelease digestion results 
obtalned in tissue culture HeLa cells. where no effect of 
RNase pretreatment of eell substrates on immunostain-
Ing w.lth a ntl-PM-Scl was observed. 
Several a ttempts were made to identify the antlgenlc 
epitopes of the PM-Sei complex by immunoblottlng ex-
periments. Extractable whole HeLa cell proleins as well 
as lsolated nucleolar proteins were separated by SDS-
PAGE and were transferred lo nitrocellulose for immu-
noblotting. At the present time. no conclusive results 
have been obtained. although a protein of approxlmately 
Mr 80.000 has been reacttve wlth some sera. Vartous 
explanatlons are possible. such as denaturation of the 
antigens and the requlrement of tertiary conformation 
for antigentcity. Definitive identtty of the antigenie com-
ponent of the PM-Sei compIex awaits further study. 
D!SCUSS!ON 
Antinucleolar antibodies are part of the spectrum of 
autoantibodies present in scIeroderma and were found to 
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Figure 6. Autorudlograrn of f"Sjrnethlonlne-labeled HeLa cell proteins 
Immunopreclpllated by an tl -PM-S I antilXldles (S 125) and resolved In a 
17.5% SDS-polyacrylamlde gel. Lunc I shows proteins preclp!tated by 
normal control serum. Lane 2 demonstratcs In detail the racllolabclccl 
pl'ote!ns from HeLa cells that a re se ieclively brought down byantl-PM-
Sei an tlbodles and are named P I -P 11 . 
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Figure 7. Autoradiogram of Immunopreclpllaled. I"Slmelhlonlne-
[Iane land 3J and 131Plorthophosphate· [Iane 2 and 4J labeled HeLa cell 
proteins. Immunopreclpl tates as obtalned wlth normal human serum are 
shown In lane l and 2 and wHh anll-PM -Scl serum In lane 3 and 4. The 
polypeptides of M, 80.000 [P3) and 20.000 IPI I J. whlch are labeled wlth 
e·Slmcth lonlne. are phosphorylated. Thc dark smear on top of lane 2 and 
4 as weil as the signal jusl above marker or M, 46.000 were sensitive to 
RNase t reatment and most probably rcprcsents coprrClplla ting RNA In 
normal human and anll-PM-Scl serum. 
be hlghly assoclated wlth this systemlc au toimmun e dls-
ease (21-24). Nucleolar 4-6 S RNA was shown to be one 
of the targets (24). More recently. a novel nucleolar ribo-
nucleoprotein complexed wlth 7-2 RNA was detected with 
antlnucleolar scleroderma antlbodles (25. 26) . U3 ribo-
nucleoprotein was also shown to be part of a complex 
precipitated by certaln antinucleolar antlbodles from 
scleroderma sera (25). These antlbodles were shown to 
recognize a M, 34.000 basic nucleolar protein rl ch in NG • 
NG-di methylarglnine. and glyci ne (27). Because of its pre-
dominant loca fl za tion in the flbrillar component of nu-
cleoli. Ochs el a l. (28) named this nucleolar protein fl -
brillarin. We recently showed that a s ubgroup of a ntf -
nucleolar a nttbodles that produce s peckled or punctate 
nucleolar immunofluorescence stainlng In tlssue culture 
ce lls Immunopreclpitated the RNA polymerase I complex 
(29). Naturally occurring autoimmune a ntibodles against 
nucleolar proteins a nd RNA protein complexes thus far 
have proved to be va luable tools to dissect nucleolus 
structure and function. 
In the present study. we have characterized the antigen 
reactlve wlth a nti -PM-Scl antl bodies that were previously 
shown to be associated wlth polymyositIs. scleroderma. 
or polymyosltis/scleroderma overla p syndromes. The pre-
dominant nucleola r presence of the PM-Scl antigen was 
demonstrated by indirect immunofluorescence per-
formed by uslng tissue culture cells [rom a variety of 
species. The wide dist ribution of the epltopes recognlzed 
by a ntf -PM-Scl autoantibodies suggests that the reactlve 
protein is a conserved a nd important cellular component. 
The nucleolar localization of the PM-Scl antigen as ob-
served In this s tudy Is in keeplng wlth a recent report by 
Ta rgoff and Reichlin (9) . who also found this antigen to 
be nucleolar. However. from our Immunolocallzation 
studies It appears that the PM-Scl a ntigen Is also present 
In the nucl eoplasm . 
Sy electron microscoplc Immunocytochemlstry. anti-
PM-Scl anUbodles predomlnantly s tal ned the granular 
component of nucleoli and clustcred pa rtlcles dispersed 
throughout the heterochromatin . In actinomycin D-seg-
regated nucleol!. anti-PM-Scl stalning was substantially 
reduced but malnly localized in the granular regions. 
AcUnomycin D In the concentratlons used In thls study 
suppresses the synthesls of rRNA and the actlvlty of RNA 
polymerase II but not the synthesls of rlbosomal proteins 
(30- 33) . In the absence of rRNA synthesls and desplte 
normal protein synthesis. rlbosomal proteins are rapldly 
degraded (32). Another drug. the halogenated adenosine 
analogue DRS. also had a markedly suppressive effect on 
the expression of the PM-Sei antigen. Thls drug almost 
completely abollshed antl-PM-Scl stalnlng In tissue cu 1-
ture cells when added to the medium . DRB Is known to 
effectively suppress the synthesls of mRNA (34- 36) but 
not. or only moderately. transcriptlon of the rRNA genes 
(37. 38). DRS causes extensive degradation of the RNA 
precursor particles of the large rlbosomal subunlt. prob-
ably due to the deficiency of essential prerlbosomäl pro-
teins. The productlon of the small ribosomal subunlt 
appears not to be Impalred (18 . 19). Therefore. local!za-
tlon of the PM-Scl antigen predominantly In the granular 
region of nucleoll. the Si te of ribosome assembly and 
packaglng. and more Importantly sensltivity of the PM-
Scl a ntigen to actinomycln D and DRB. drugs that cause 
degradation of preribosomes. may suggest a relatIonship 
of the PM-Scl antigen to prerlbosomes. Th e distribution 
of the PM-Scl antigen durlng cell cycle is compatlble with 
a posslble prerlbosomaJ origln or assoclation. 
On a molecular level. a nti -PM-Sc l a ntlbodies Immuno-
precipltated 1I polypeptides with M, from 110.000 to 
20.000 when incubated wlth [35Slmethlonlne-labeled 
HeLa cell proteins from the extractable fractlon . The M, 
80.000 and 20.000 polypeptides were phosphorylated. 
RNA was not preclpitated wlth the PM-Scl antigen. and 
therefore. no association of the PM-Scl complex wlth 
ribosoma l precursor RNA or processed rRNA could be 
establlshed that cou ld have facilltated Identiflcatlon of 
the putative nature of the PM-Scl antigen . We also at-
lempted to defl ne the anUgenlc components of the PM-
Scl antigen complex recognlzed by autoimmune anti-
bodles. Wlth the use of extractable HeLa cell proteins as 
weil as Isolated nucleoli as antigen sour e in Immuno-
blotting. the antIgenie polypeptides of the PM-Scl com-
plex could not be concluslvely revealed . 
The PM-Scl antigen. however. Is clearly different from 
the 7-2 rlbonucleoprotein parUcle recognlzed by certaln 
antlnucleolar scleroderma sera (25 . 26) slnce none of our 
anti-PM-Scl sera coprecipltated 7-2 S RNA . U3 RNA was 
also not present in the immunopreclpltates of anti-PM-
Sei anUbodles. suggesting that the U3 rlbonucleoproteln 
is not part of the PM-Scl complex . We also incubated 
deprotei nized RNA wlth an ti -PM-Scl a ntibodies and 
showed that RNA was not a target. suggesting that these 
antibodles are different from those reported to react wlth 
4-6 S nucleolus-specific RNA (24) or any other RNA spe-
cies. 
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Polyclonal and monoclonal antibodles have recently 
been used by several Investigators to characterize nu-
cleolar proteins In greater detail. For example, a mouse 
monoclonal antibody was shown by HugIe et al. (39) to 
Identlfy the largest and most acldlc protein of the small 
ribosomal subunlt (SI) wlth Mr 43,OOO In the rat. Another 
monoclonal antibody characterlzed a nuclear Mr 40,000 
protein named ribocharin, whlch appears to be speclflc 
to precursor particles of the large ribosomal subunit In 
Xenopus laevis and other amphlbla (40). Recently. a Mr 
100.000 nucleolar protein was Identlfled as belng asso-
clated wlth preribosomes (41). Other nucleolar proteins 
that have been partlally characterized Include protein 
C23 and B23. In severa] reports. lt has been suggested 
that protein C23 may be a component of the preribosomal 
rlbonucleoproteln partlc1es (42, 43) and protein B23 may 
be associated wtth ribosome assembly and packaglng (44. 
45). It is unclear at the moment whether some of the PM-
SeI polypeptides are identical with known nucleolar pro-
teins, but 1t is conceivable. Further characterlzation of 
the PM-SeI complex is needed to answer 11s exact com-
position and functlon in the nucleolus. 
Deflnlng the structure and functlon of the PM-Scl au-
toantlgen may be a first step towards understandlng why 
patients wlth features of polymyositIs and scJeroderma 
eUcH an autoimmune response dlrected against thls nu-
cJeo]ar macromolecule. 
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